Stock screenerAll disclosures →
EDGAR →
VTRS
Conviction 45HealthcareScan · Mon, Aug 10, 2026VTRS$16.27-0.97%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 11.34M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price16.27
Change-0.97%
Gap-0.61%
Rel volume1.49×
Avg volume10.57M
Avg $ vol181.15M
SMA 2017.22
SMA 5016.55
SMA 20014.15
Price vs 50-1.69%
Price vs 200+14.96%
MA stackmixed
50/200 cross—
Supertrenddown · 18.23
RSI (14)40
MACD hist-0.19
MACD crossbear · 2d
Stoch %K / %D6 / 7
ADX (14)21
+DI / −DI17 / 24
RSI divergenceBearish
MACD divergenceBearish
ATR %+3.53%
ADR %3.29%
52w high17.86
52w low9.49
From 52w high-8.90%
Above 52w low+71.44%
New 52w highNo
SqueezeOff
Bollinger width12.40%
%B0.06
Donchian pos6.61%
Donchian high18.39
Donchian low16.12
AVWAP (52w high)16.65
vs AVWAP high-2.29%
AVWAP (52w low)13.53
vs AVWAP low+20.24%
OBV trendDown
Chaikin MF (20)-0.03
Today vs 20d1.49×
Avg vol (14d)11.34M
Avg vol (20d)10.57M
Avg $ vol (20d)181.15M
Market cap—
RS 3m (vs SPY)-11.22%
RS 6m (vs SPY)+0.46%
RS line new highNo
Trend template6/8
Technical rank50.1
1 week-7.71%
1 month+0.00%
3 months-5.24%
6 months+11.59%
1 year+73.27%
YTD+30.58%
P/E—
P/B-93.77
P/S1.32
P/FCF9.73
EPS-3.00
Div yield—
ROE0.00%
ROA0.00%
Debt/Eq-66.42
Current1.58
EV/EBITDA231.61
Gross margin35.18%
Net margin0.00%
Rev growth-3.01%
EPS growth—
Price target18.43
Target upside12.31%
Analyst ratingBuy
Institutional99.11%
Ent. value31.31B
Revenue3.75B
Net income-169M
Gross profit1.46B
Free cash flow1.94B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out1.16B
Employees30K
ListedFri, Feb 23, 1973
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction45 / 100
Pattern quality—
Tech rank50.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance18.23
Support15.37
Days since event—
Candle confirm—
News sentiment—
Financials as of Sun, Sep 27, 2020 · quarterly.
Congress activity
Disclosed STOCK Act trades in VTRS · 3 recent
Insider activity
SEC Form 4 transactions in VTRS · 2 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Campbell Paul See Remarks · Common Stock · 2026-06-25 | Sell | 50.08K | $810K | 2026-06-25 | 2026-06-26 |
Le Goff Corinne Chief Commercial Officer · Common Stock · 2026-04-15 | Tax | 17.45K | $242K | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Common Stock · 2026-04-15 | Exercise | 39.34K | $0 | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Common Stock · 2026-04-15 | Exercise | 3.64K | $0 | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Dividend Equivalent Units · 2026-04-15 | Exercise | 3.64K | $0 | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Common Stock · 2026-04-15 | Tax | 1.62K | $22K | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Restricted Stock Units · 2026-04-15 | Exercise | 39.34K | $0 | 2026-04-15 | 2026-04-16 |
SEC filings
EDGAR filings in VTRS · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.